Home » Current Affairs » News Digest 11 – 17 July 2020 | Current Affairs

News Digest 11 – 17 July 2020 | Current Affairs

Employment News 11 – 17 July 2020

News Digest


  • Indian COVID 19 vaccines are in the global race to end the coronavirus pandemic. ICMR has partnered with Bharat Biotech International Limited to develop COVAXIN, whereas Zydus Cadila is working on ZyCov-D Vaccine. Indian Council of Medical Research (ICMR) had written to 12 Medical Institutes in the country to start the first phase of Human Clinical Trials by registering volunteers. Maximum numbers of these Institutes have begun the subject enrolment process. With the beginning of enrollment of volunteers, the two Indian vaccine candidates will now be tested on 1,125 healthy volunteers in the two phases of trials. The vaccines will be evaluated for its safety, reactogenicity, tolerability and immunogenicity. Volunteers will be administered two intramuscular shots. The proposed age groups for the trials are 18-55 years for Phase I and 12-65 years for Phase II. Across the world, more than 140 candidate vaccines are under various stages of Indian manufacturers account for 60 percent of vaccine supplies made to UNICEF.
  • The Health Ministry has said that India has effectively dealt with the Covid-19 pandemic and the country has the lowest caseloads and deaths in terms of its population in comparison to other nations. It said, there is no community transmission in the country. India has 538 cases per million in comparison to the global average of 1497. In terms of death rate, India has 15 deaths per million compared to the global average of 69.3. The Health Ministry said, recovered cases are progressively rising and the total recoveries reached 1.75 times of the active cases. People between the age group from 45 to above 75 constitute 26 per cent of the population and most of the deaths have been registered in this age group. Most of the 39 percent deaths have been registered in the age group of 60 to 74 which is eight percent of the total population. The Health Ministry said, a total of 4, 76, 378 people affected with coronavirus have recovered in the country so far. ICMR is continuously scaling up its testing facilities for Covid-19 by giving approval to government and private laboratories. As of now, total 1,132 laboratories across India have been given approval to conduct the test for Covid-19 including 805 government laboratories and 327 private laboratories’ chains.
  • The Central Board of Secondary Education (CBSE) has clarified that topics mentioned in certain media reports as dropped from the syllabus are either being covered by the rationalized syllabus or are in the Alternative Academic Calendar of NCERT. In a press statement, the CBSE has informed that the Alternative academic calendar of NCERT is already in force for all the affiliated schools of the board. It said, the rationalization of syllabus of up to 30 per cent has been undertaken for nearly 190 subjects. The Board further highlighted that the cut down in syllabus from class 9th to 12th for the academic session 2020-21 is a one time measure. The Board maintained that the objective of the current rationalization is to reduce the exam stress of students due to the prevailing health emergency situation and to prevent learning gaps. CBSE has clarified that no question will be asked from the truncated syllabus in the Board Exams of 2020-21. CBSE informed that the schools have also been directed to follow the Alternative Academic Calendar prepared by NCERT for transacting the curriculum.


  • Infosys chairman Nandan Nilekani has said that India stands to benefit from the current global situation as more countries look for alternatives to China. He said, the covid-19 crisis will create new opportunities for the Indian IT services industry as clients look at consolidation and reduce the number of suppliers. Mr. Nilekani was speaking at the company’s internal platform, InfyTV. He said companies will see a balance between working from office and working from home as around the world billions of people have tested the work from home model two to three months at a stretch. Mr. Nilekani said, there will be a new equilibrium, which has an impact on mobility, traffic, the way cities are designed.


  • The World Health Organization has acknowledged that evidence is emerging about the airborne spread of the Novel Coronavirus. Maria Van Kerkhove, technical lead on the COVID-19 pandemic at the WHO, told a news briefing that there was a discussion about the possibility of airborne transmission and aerosol transmission as one of the modes of transmission of COVID-19. She said the WHO would publish a scientific brief summarising the state of knowledge on modes of transmission of the virus in the coming days. The health agency had previously said the virus that causes the COVID-19 respiratory disease spreads primarily through small droplets expelled from the nose and mouth of an infected person that quickly sink to the ground. But a group of scientists in 32 countries outlined evidence that shows floating virus particles that can infect people who breathe them in. They had urged the global body to its guidance on how the respiratory disease passes between people.
  • US Secretary of State Mike Pompeo has said America is looking at banning Chinese social media apps, including TikTok. He told a TV channel that Trump Administration is certainly looking at banning these apps as they shared information with the Chinese government. US lawmakers have raised national security concerns over TikTok’s handling of user data. They were worried about Chinese laws requiring domestic companies to support and cooperate with intelligence work controlled by the Chinese Communist Party. Mr. Pompeo’s remarks also come amid increasing USChina tensions over the handling of the coronavirus outbreak, China’s actions in Hong Kong and a nearly two-year trade war.
  • India and the US have reaffirmed their commitment to work towards ensuring a free, open, inclusive, peaceful and prosperous Indo-Pacific. They also agreed on the need to deepen cooperation in the United Nations, especially during India’s membership of the United Nations Security Council. Foreign Secretary Harsh Vardhan Shringla and the US Under Secretary of State for Political Affairs David Hale exchanged views on a number of regional and global issues of shared interests during the virtual foreign office consultations between the two countries. They reviewed the entire gamut of engagements under the India-US Comprehensive Global Strategic Partnership, including political, economic, commercial, regional and international cooperation. In the backdrop of the COVID-19 pandemic, they agreed to further strengthen the bilateral health partnership, including on pharmaceuticals and vaccine development. They agreed to remain in touch and move forward on the bilateral agenda through a range of mechanisms like the 22 ministerial that India will host later this year.


  • Cricket icon Sachin Tendulkar recently inaugurated a Plasma Therapy Unit for treating COVID-19 patients at the Seven Hills Hospital in suburban Andheri. He urged those who have recovered from the deadly infection to help save lives by donating blood plasma. The unit is an initiative of the Brihanmumbai Municipal Corporation (BMC). It will offer convalescent plasma therapy to COVID-19 patients using donated blood plasma from those who have recovered. The ace batsman said researchers around the globe are working to find an effective vaccine and treatment. In this, plasma therapy has emerged as an option to treat critically ill patients.

Website: http://employmentnews.gov.in/

Details: [pdf-embedder url=”https://www.miliposts.in/wp-content/uploads/2020/07/Employment-News-11-17-July-2020-New-Digest.pdf” title=”Employment News 11 – 17 July 2020 New Digest”]

Deputy Manager and Manager Post | Export-Import Bank of India Read more: https://www.miliposts.in/bank-jobs/deputy-manager-and-manager-post-export-import-bank-of-india/#ixzz6Z2l6Lj7j


Leave a Reply

Your email address will not be published. Required fields are marked *

Name *
Email *